Why We Should Care About Ion Channels “… ion channels are the most important single class of proteins that exist in the human body or any body…” Clay Armstrong
. What Are Ion Channels We all think differently and use different words/associations to describe the same thing. See how different scientists define ion channels. Fundamentals Nobel Prizes for the discoveries concerning ion channels Fundamentals History Of Ion Channels Fundamentals Ion Channel News: 07/04/2021 Metrion Biosciences raises £2.7m and adds GLP cardiac safety services to the suite of ion channel drug discovery services 12/03/2021 CalciMedica Raises $21 Million in Series D Financing to support the clinical development of CRAC channel inhibitors 22/12/2020 FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations 22/12/2020 Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders 18/12/2020 Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19 17/12/2020 Cadent Therapeutics and its ion channel programs to be acquired by Novartis 16/12/2020 Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain Read more news here Chief Scientific Officer at Nanion, Andrea Brüggemann, on automated patch clamp in academia, ion channel industry and fundraising INTERVIEWS Ion Channel DRUGS Resource Ion Channel COMPANIES Resource Ion Channel LABS Resource Membrane Transport Infographic Electrical Signals Infographic Permeability Of Lipid Bilayers Infographic
What Are Ion Channels We all think differently and use different words/associations to describe the same thing. See how different scientists define ion channels. Fundamentals
07/04/2021 Metrion Biosciences raises £2.7m and adds GLP cardiac safety services to the suite of ion channel drug discovery services 12/03/2021 CalciMedica Raises $21 Million in Series D Financing to support the clinical development of CRAC channel inhibitors 22/12/2020 FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations 22/12/2020 Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders 18/12/2020 Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19 17/12/2020 Cadent Therapeutics and its ion channel programs to be acquired by Novartis 16/12/2020 Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain
Chief Scientific Officer at Nanion, Andrea Brüggemann, on automated patch clamp in academia, ion channel industry and fundraising INTERVIEWS